➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Medtronic
Express Scripts
Baxter
Harvard Business School

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Methylergonovine maleate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for methylergonovine maleate and what is the scope of freedom to operate?

Methylergonovine maleate is the generic ingredient in two branded drugs marketed by Edison Theraps Llc, Am Regent, Breckenridge, Amneal Pharms, Granules Pharms, Novel Labs Inc, Teva Pharms Usa, and Tulex Pharms Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for methylergonovine maleate. Fourteen suppliers are listed for this compound.

Drug Prices for methylergonovine maleate

See drug prices for methylergonovine maleate

Recent Clinical Trials for methylergonovine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brigham and Women's HospitalPhase 4
Johns Hopkins UniversityEarly Phase 1
University of California, San FranciscoPhase 4

See all methylergonovine maleate clinical trials

Pharmacology for methylergonovine maleate
Medical Subject Heading (MeSH) Categories for methylergonovine maleate

US Patents and Regulatory Information for methylergonovine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Edison Theraps Llc METHERGINE methylergonovine maleate TABLET;ORAL 006035-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Edison Theraps Llc METHERGINE methylergonovine maleate INJECTABLE;INJECTION 006035-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Tulex Pharms Inc METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 212233-001 May 1, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Granules Pharms METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 210424-001 May 15, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Am Regent METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 090193-001 Nov 24, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Breckenridge METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 040889-001 Sep 13, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 211455-001 Mar 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
McKesson
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.